Medical Ozone Generator Market to Surpass US$ 172.5 Million by 2028

Global Medical Ozone Generator Market, by Type (Trolley-mounted and Table-top), by Application (Oncological Treatment, Dermatological Treatment, Gastrointestinal Treatment, Dental Treatment, Gynecologic Treatment, and Others), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) is estimated to be valued at US$  115.9 Mn in 2021 and is expected to exhibit a CAGR of 5.8% during the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.

Increasing prevalence of gastrointestinal disease is expected to propel growth of the global medical ozone generator market over the forecast period. Ozone is widely used in the gastrointestinal treatment. For instance, according to an article published in National Center for Biotechnology Information (NCBI) in 2018, it is estimated that in the U.S. 11% of the population suffer from a chronic digestive disease, with a prevalence rate as high as 35% for those 65 years and above.

Global Medical Ozone Generator Market– Impact of Coronavirus (COVID-19) Pandemic

Governments and government agencies globally are taking various initiatives to combat the spread of COVID-19. For instance, in May 2020, the Centers for Disease Control and Prevention started working with the All-of-Government and All-of-America approach to increase testing capacity, improve case detection, and contact tracing across all the U.S. states and re-open the country. Various leading pharmaceutical and technological companies are collaborating with the U.S. government for faster clinical development of the vaccines for prevention of the COVID-19 infections in the U.S.  For instance, in July 2020, IQVIA, a clinical service company, and Astra Zeneca, a pharmaceutical company, announced the collaboration with the U.S. government for Operation Warp Speed project. Operation Warp Speed is a part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The specific IQVIA and AstraZeneca collaboration will drive faster delivery of clinical studies in the U.S. aimed at demonstrating efficacy of AstraZeneca’s potential COVID-19 vaccine, AZD1222.

Browse 35 Market Data Tables and 33 Figures spread through 204 Pages and in-depth TOC on “Global Medical Ozone Generator Market”-  Forecast to 2028, Global Medical Ozone Generator Market, by Type (Trolley-mounted and Table-top), by Application (Oncological Treatment, Dermatological Treatment, Gastrointestinal Treatment, Dental Treatment, Gynecologic Treatment, and Others), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the Global Medical Ozone Generator Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/medical-ozone-generator-market-4940

Moreover, Ozone effectiveness in neutralizing coronavirus is expected to drive the growth of global medical ozone generator market. For instance, according to case study published in American Journal of Case Reports in August 2020, stated that Oxygen Ozone therapy appears to be an effective therapy for COVID-19 patients with severe respiratory failure

Key Takeaways of the Global Medical Ozone Generator Market:

• The global medical ozone generator market is expected to exhibit a CAGR of 5.8% during the forecast period due to increasing the incidence of skin disease, which is expected to boost growth of the market. For instance, according to National Eczema Association, it is estimated that 31.6 million people (10.1%) in the U.S. have some form of eczema.
• In terms of end user, hospitals and clinics segment is estimated to hold largest market share in global medical ozone generator market over the forecast period. Increasing number of patients suffering from cancer, which is expected to drive demand for hospital administration of patient for the treatment of cancer. For instance, in 2017, there were 2.8 million cancer-related nonmaternal hospitalizations among adults in the U.S., accounting for 10.5% of the 26.4 million adult nonmaternal hospitalizations.
• Among regions, North America is estimated to hold dominant position in global medical ozone generator market in 2021. Ozone therapy is commonly and effectively used to treat the herpes virus. Increasing of prevalence of herpes simplex virus is estimated to drive the growth of the segment. For instance, according to Centers for Disease Control and Prevention in 2018, it is estimated that during 2015–2016, prevalence of herpes simplex virus type 1 (HSV-1) was 47.8%, and prevalence of herpes simplex virus type 2 (HSV-2) was 11.9%.
• Major players operating in the global medical ozone generator market include Medozons Ltd., AQUAZONE SYSTEMS & ENGINEERING, Eltech Ozone, Chemtronics, AQUAPURE, MIO International Ozonytron, Herrmann Apparatebau, EVOZONE GmbH, Dr. J. Hänsler GmbH, Aquolab, APOZA Enterprise, W and H Dentalwerk Bürmoos, and Promolife